Elekta (OTCMKTS:EKTAY) Sees Strong Trading Volume – Here’s Why

Shares of Elekta AB (OTCMKTS:EKTAY) saw unusually-high trading volume on Tuesday . Approximately 10,054 shares were traded during trading, an increase of 282% from the previous session’s volume of 2,634 shares.The stock last traded at $5.9850 and had previously closed at $5.87.

Elekta Trading Up 0.4%

The stock has a market cap of $2.21 billion, a PE ratio of -597.90 and a beta of 1.07. The firm has a 50-day moving average price of $6.28 and a 200-day moving average price of $5.69. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.79 and a current ratio of 1.04.

Elekta (OTCMKTS:EKTAY) last announced its quarterly earnings data on Thursday, March 5th. The company reported $0.09 EPS for the quarter. The company had revenue of $433.29 million for the quarter. Elekta had a negative net margin of 0.08% and a positive return on equity of 12.72%. As a group, equities analysts anticipate that Elekta AB will post 0.36 EPS for the current fiscal year.

About Elekta

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.